## Abstract We have applied the macrophage migration inhibition assay to study cell‐mediated immune responses to antigens of polyoma‐virus‐transformed cells. Macrophages from polyoma‐virus‐immunized mice, but not from control mice, showed significant migration inhibition when exposed to extracts of
Polyoma t-antigen-derived synthetic peptides induce polyoma-virus-specific macrophage migration inhibition
✍ Scribed by Git Reinholdsson; Torbjörn Ramqvist; Robert Sziget; Tina Dalianis
- Publisher
- John Wiley and Sons
- Year
- 1989
- Tongue
- French
- Weight
- 428 KB
- Volume
- 43
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Synthetic peptides, 2 derived from the sequence common to small, middle and large T-antigen, and I derived from the sequence unique for middle T, activated lymphocytes from polyoma-virus-immunized, but not from control mice, to release the lymphokine migration inhibitory factor (MIF). In contrast, purified, bacterially grown, full-length small Tantigen and a middle T-antigen mutant Py 1387T MT (lacking 37 C-terminal amino acids) did not induce lymphokine release, although they were capable of inducing an antipolyoma TSTA response in vivo.
📜 SIMILAR VOLUMES
We have used 9 synthetic peptides corresponding to sequences of polyoma virus small-T, middle-T and large-T antigens as immunogens in order to map antigenic epitopes that can induce polyoma-tumor-specific immunity in different mouse strains. We found that immunization of mice with synthetic peptides
Mice and rats could be immunized against the polyoma-virus-induced tumor-specific transplantation antigen (TSTA) by repeated inoculation of frozen or irradiated cells of an MT-cDNA-transformed rat cell line (2.8) that contains only the polyoma middle T-antigen, or by cells that carried a host range